is there an oral glp-1 Liquid Therapy for Metabolic & Weight Health Oral GLP-1 Therapy: Pills vs

The protective actions of GLP-1RAs in the heart involve GLP-1R, kinases (protein kinase C epsilon (PKC), PKA, Akt, adenosine 5 -monophosphate-activated protein kinase (AMPK), PI3K, extracellular signal-regulated kinase 1 and 2 (ERK1/2), mammalian target of rapamycin (mTOR), glycogen synthase kinase-3 (GSK-3), protein kinase G (PKG), mitogen activated protein kinase 1 and 2 (MEK1/2), and mitogen activated protein kinase 3 (MKK3)), enzymes (heme oxygenase 1 (HO-1) and endothelial nitric oxide synthase (eNOS)), transcription factors (signal transducer and activator of transcription 3 (STAT3), cAMP-response element binding protein (CREB), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), and forkhead box protein O3 (FoxO3)), adenosine triphosphate-sensitive potassium channel (KATP) channel opening, and mitochondrial permeability transition pore closure [49]

Fahima Azizi MD and Dr

Likely both

LY3437943 may cause greater weight loss than Tirzepatide , a dual GIPR and GLP-1R agonist that has shown improved weight loss compared to selective GLP-1R agonists in patients with type 2 diabetes

"New study confirms GLP-1 medications are safe for mental health in diabetes"

doi:10.1016/j.lfs.2004.03.024 34